Skip to main content

Mangoceuticals, Inc.

MGRX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001938046

No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Mangoceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
8
+3 vs. Q4 2023
Shares held
328.5K
+201.0K (+157.7%) vs. Q4 2023
Total value
$72.0K
+$37.1K (+106.5%) vs. Q4 2023
New holders
5
2 more added
Sold out
2
0 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 8 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 1 institutionQ2 2023: 5 institutionsQ3 2023: 9 institutionsQ4 2023: 5 institutionsQ1 2024: 8 institutionsQ2 2024: 6 institutionsQ3 2024: 13 institutionsQ4 2024: 9 institutionsQ1 2025: 8 institutionsQ2 2025: 10 institutionsQ3 2025: 11 institutionsQ4 2025: 18 institutionsQ1 2026: 18 institutionsQ2 2026: 18 institutions
Value heldQ1 2024: $72.0K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $5.32KQ2 2023: $166.4KQ3 2023: $135.8KQ4 2023: $34.9KQ1 2024: $72.0KQ2 2024: $147.7KQ3 2024: $319.7KQ4 2024: $220.9KQ1 2025: $146.9KQ2 2025: $444.2KQ3 2025: $820.1KQ4 2025: $1.88MQ1 2026: $297.6KQ2 2026: $455.6K
Institutions holding MGRX and their total value by quarter
QuarterHoldersValue
Q2 202618$455.6K
Q1 202618$297.6K
Q4 202518$1.88M
Q3 202511$820.1K
Q2 202510$444.2K
Q1 20258$146.9K
Q4 20249$220.9K
Q3 202413$319.7K
Q2 20246$147.7K
Q1 20248$72.0K
Q4 20235$34.9K
Q3 20239$135.8K
Q2 20235$166.4K
Q1 20231$5.32K
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Mangoceuticals, Inc.; share changes are against Q4 2023.

Institutions holding MGRX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC114,403$25.2K0.00%+92,092+412.8%Added
Mercer Global Advisors Inc100,000$22.0K0.00%+100,000New
McCollum Christoferson Group LLC42,700$9.26K0.00%+15,000+54.2%Added
XTX Topco Ltd24,352$5.36K0.00%+24,352New
Federation des caisses Desjardins du Quebec22,000$4.77K0.00%00.0%Unchanged
UBS Group AG14,447$3.13K0.00%+14,447New
Morgan Stanley10,358$2.25K0.00%+10,358New
BFSG, LLC200$440.00%+200New
Renaissance Technologies LLC0$00.00%−30,458−100.0%Sold out
Vanguard Capital Wealth Advisors0$00.00%−25,000−100.0%Sold out